Filing Details
- Accession Number:
- 0001209191-17-064066
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-05 19:38:30
- Reporting Period:
- 2017-12-01
- Accepted Time:
- 2017-12-05 19:38:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1513818 | Versartis Inc. | VSAR | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1253170 | Srinivas Akkaraju | C/O Versartis, Inc. 1020 Marsh Road Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-12-01 | 419,700 | $2.13 | 991,129 | No | 4 | P | Indirect | see footnote |
| Common Stock | Acquisiton | 2017-12-04 | 513,872 | $2.21 | 1,505,001 | No | 4 | P | Indirect | see footnote |
| Common Stock | Acquisiton | 2017-12-05 | 42,895 | $2.00 | 1,547,896 | No | 4 | P | Indirect | see footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | see footnote |
| No | 4 | P | Indirect | see footnote |
| No | 4 | P | Indirect | see footnote |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 14,955 | Direct |
Footnotes
- Represents the weighted average purchase price of the Shares purchased ranging from a low of $1.975 to a high of $2.25 per share. The reporting person undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Shares held by Samsara BioCapital, L.P. ("Samsara BioCapital"). The reporting person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara BioCapital. The Reporting Person disclaims beneficial ownership of these shares except to the extent of the Reporting Person's pecuniary interest therein.
- Represents the weighted average purchase price of the Shares purchased ranging from a low of $2.125 to a high of $2.25 per share. The reporting person undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
